• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FDA Clearance

Philips Awarded FDA Clearance for Wearable Biosensor to Monitor COVID-19 Patients

by Fred Pennic 05/26/2020 Leave a Comment

Philips Awarded FDA Clearance for Wearable Biosensor to Monitor COVID-19 Patients

What You Should Know: Wireless wearable biosensor (Philips Biosensor BX100) receives 510(k) clearance from the FDA and CE mark to help monitor COVID-19 patients in the hospital, with the first install at OLVG Hospital in the Netherlands Philips Biosensor BX100 enhances Philips portfolio of devices, software, and services for identifying patients at risk for deterioration while limiting exposure to help improve staff and patient safety and preserve valuable personal protective equipment.
Read More

Zebra Medical Vision Secures 5th FDA Clearance for Vertebral Compression Fractures AI Solution

by Jasmine Pennic 05/18/2020 Leave a Comment

Zebra Medical Vision Secures 5th FDA Clearance for Vertebral Compression Fractures AI Solution

What You Should Know: - Israeli deep-learning medical imaging analytics startup Zebra-Med secures its fifth FDA clearance vertebral compression fractures AI solution for availability in the U.S. - The AI solution will help health providers close the COVID-19-induced care gaps by identifying more patients at risk of osteoporosis, also known as the “silent killer,” costing over $52B in the U.S. alone.  - Zebra-Med is one of the first companies in the industry to provide an AI
Read More

FDA Expedites Clearance for AI Ultrasound Solution to Fight COVID-19

by Fred Pennic 05/12/2020 Leave a Comment

FDA Expedites Clearance for AI Ultrasound Solution to Fight COVID-19

What You Should Know: - FDA expedites clearance of Caption Health’s AI-powered ultrasound solution to aid frontline healthcare workers in the fight against COVID-19 pandemic. - Caption Health’s AI-guided imaging supports the assessment of cardiac function and decreases personnel exposure to novel coronavirus. In response to the growing body of evidence demonstrating the impact of COVID-19 on the heart, the U.S. Food and Drug Administration (FDA) has expedited clearance of an update
Read More

Lumos Diagnostics Raises $15M to Expand Point of Care Diagnostic Solutions Internationally

by Jasmine Pennic 02/05/2020 Leave a Comment

Lumos Diagnostics Raises $15M to Expand Point of Care Diagnostic Solutions

- Lumos Diagnostics raises $15M in Series A funding to support the international expansion of its point of care diagnostic solutions. - Lumos provides assay development and manufacturing services for customized POC tests as well as directly develops, manufactures and will commercialize a suite of proprietary Lumos-branded POC tests that focus on the systemic host immune response. Lumos Diagnostics, a Sarasota, FL-based health IT company, today announced it has raised $15M in Series A
Read More

Sony Awarded FDA Clearance for Smart Operating Room Platform in the U.S.

by Fred Pennic 01/30/2020 Leave a Comment

Sony Awarded FDA Clearance for Smart Operating Room Platform in U.S.

- Sony announces FDA 510(k) clearance from the FDA for NUCLeUS™, the smart operating room platform, for sale in the U.S. - NUCLeUS provides an enhanced, streamlined workflow for operating rooms and clinical spaces with direct access to imaging data from an easy-to-use central dashboard.  Sony Electronics has received FDA 510(k) clearance from the Food and Drug Administration for the company’s NUCLeUS™ Operating Room, Imaging Management and Collaboration Control platform. Proven in
Read More

BioIntelliSense Awarded FDA 510(k) Clearance for On-Body Sensor for Scalable Remote Care

by Jasmine Pennic 01/28/2020 Leave a Comment

BioIntelliSense Awarded FDA 510(k) Clearance for On-Body Sensor for Scalable Remote Care

- BioIntelliSense announces FDA clearance of the BioSticker, the first single-use medical device enabling 30 days of continuous vital signs monitoring. - The FDA-cleared BioSticker medical device is designed to be discreetly worn on the upper left chest for effortless remote data capture and a simplistic “stick it on and forget it” patient experience.  BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the U.S. commercial launch of its
Read More

FDA Breakthrough Status Granted for Heart Failure Algorithm by Eko

by Jasmine Pennic 12/18/2019 Leave a Comment

FDA Breakthrough Status Granted for Heart Failure Algorithm by Eko

- Eko announced the FDA has granted “breakthrough status” for an algorithm that could provide an easily accessible screening test for heart failure during routine physical exams.- This designation is awarded to novel innovations that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases. - Heart failure is often left untreated until it’s too late due to costs, inaccessibility to echocardiogram testing, or misdiagnosis. With nearly six
Read More

Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem to Accelerate Biomarker Discovery

by Fred Pennic 12/18/2019 Leave a Comment

Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem

- Paige raises $45M in Series B funding  led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others.   - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada.    Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More

Unlike Theranos: FDA Clears Sight Diagnostics’ Finger-Prick Blood Test for U.S. Market

by Fred Pennic 12/06/2019 Leave a Comment

FDA Clears Smart Diagnostic’s Finger-Prick Blood Test for U.S. Market

- Sight Diagnostics, the company working to provide patients with lab-grade blood testing results in minutes, has received US FDA 510(k) clearance for its finger-prick blood test, OLO analyzer to be used in laboratories run by diagnostic providers and hospitals.  - Sight Diagnostics’ patented OLO analyzer digitizes blood into images to perform the most common blood test in minutes, from just two drops of blood - The FDA clearance follows clinical trials at Boston Children’s Hospital,
Read More

Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope, Mayo Clinic and Eko Finds

by Fred Pennic 11/18/2019 Leave a Comment

Eko Duo Receives FDA Clearance to Market Combined Digital Stethoscope/ECG Smart Device

- Eko and Mayo Clinic announced they have proven that heart failure is detectable during routine physical exams, further validating the Eko DUO digital stethoscopes as a heart failure screening tool. - Today’s news marks the first time that a point of care device with a single lead ECG combined with an AI algorithm identified low ejection fraction in patients.- The results of these findings, which are comparable to research published earlier this year in NatureMedicine, were presented over the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |